BSE · 539938
Medico Intercontinental Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹14 Cr with net profit ₹1 Cr — a 4.31% net margin, versus 4.26% the period before.
Shareholding
As of 2026-09-30
- Promoter58.51%
- Public41.49%
3,446 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.09× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #348 of 693 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,63,802 Cr | 101.43 | 3.71 | 3.66% | 4.59% |
| Avenue Supermarts Limited | ₹2,24,349 Cr | 71.98 | 8.6 | 11.94% | 4.2% |
| Trent Ltd. | ₹1,68,779 Cr | 88.12 | 21.69 | 24.4% | 8.62% |
| FSN E-Commerce Ventures Ltd. | ₹1,04,618 Cr | 314.83 | 63.16 | 19.49% | 2.85% |
| Aditya Infotech Limited | ₹50,886 Cr | 82.37 | 13.87 | 16.16% | 10.38% |
| Vishal Mega Mart Limited | ₹45,148 Cr | 50.19 | 5.7 | 11.37% | 6.45% |
| Aegis Logistics Limited | ₹42,976 Cr | 32.26 | 6.45 | 20.01% | 14.99% |
| Premier Energies Limited | ₹40,670 Cr | 22.98 | 7.88 | 34.23% | 19.11% |
| Redington Limited | ₹27,339 Cr | 13.62 | 2.54 | 18.62% | 1.31% |
| Honasa Consumer Limited | ₹16,378 Cr | 57.17 | 11.02 | 19.03% | 10.3% |
| Medico Intercontinental Limited(this company) | ₹25 Cr | — | 0.54 | -3.64% | -1.96% |
AI analysis
AI-generated · google/gemini-2.5-flashMedico Intercontinental Limited has a market capitalization of Rs 26 Cr. The company reported revenue of Rs 96.37 Cr and has a negative profit margin of -380.5%. The debt-to-equity ratio stands at 0.23. The promoter shareholding is 58.514%, with no shares pledged.
Positives
- +The debt-to-equity ratio is low at 0.23.
- +Promoter holding of 58.514% indicates significant insider ownership.
- +There are no promoter shares pledged.
Negatives
- −The company has a negative profit margin of -380.5%.
- −Return on equity (ROE) is negative at -6.83%.
- −Return on capital employed (ROCE) is negative at -1.036%.
- −The company is under LT-ASM Stage 1 surveillance.
- −Net profit has been consistently negative in recent quarters, reaching -0.65 Cr in Mar 2026.
Financial performance
Medico Intercontinental Limited recorded revenue of Rs 96.37 Cr. The company's annual revenue was Rs 15.82 Cr in Mar 2026, Rs 12.75 Cr in Dec 2025, and Rs 12.42 Cr in Sept 2025. Quarterly revenue was Rs 22.49 Cr in Mar 2026 and Rs 19.85 Cr in Dec 2025. Net profit was -0.65 Cr in Mar 2026 and -0.22 Cr in Dec 2025.
Profitability & returns
The company has an annual profit margin of -380.5%. Return on equity (ROE) is -6.83% and return on capital employed (ROCE) is -1.036%. The net profit in Mar 2026 was -0.65 Cr and -1.65 Cr in Sept 2025.
Balance sheet
Medico Intercontinental Limited has a book value per share of Rs 46.89. The debt-to-equity ratio is 0.23, indicating a low level of debt relative to equity.
Ownership & pledges
The public shareholding is 41.486%. There is no DII or FII holding reported. No shares have been pledged by the promoters.
Regulatory & surveillance
The company is currently under LT-ASM (Additional Surveillance Measure) Stage 1, indicating enhanced monitoring by regulatory bodies.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Medico Intercontinental Limitedshare price & fundamentals